| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
357,741,000 |
| Market
Cap: |
133.31(B) |
| Last
Volume: |
2,314,661 |
Avg
Vol: |
1,355,641 |
| 52
Week Range: |
$258.49 - $400.59 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NASDAQ COMPOSITE |
| |
NASDAQ-100 |
|
S&P 400 MIDCAP |
| |
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 1071 |
| Guru Rank Value : -4.4 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Intuitive Surgical develops, manufactures, and markets the da Vinci® Surgical System and the Ion® endoluminal system. The systems consist of a surgeon console or consoles, a patient-side cart, a vision system, and proprietary instruments and accessories. Co.'s technology is designed to provide surgeons with a range of articulation of the surgical instruments used in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon's hand. Co.'s platform for robotic-assisted surgery, da Vinci Surgical System, allows surgeons to operate while seated at a ergonomic console viewing a three-dimensional, high definition image of the surgical field.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
42,158 |
277,077 |
407,354 |
786,949 |
| Total Sell Value |
$16,396,149 |
$106,728,716 |
$146,456,791 |
$241,935,425 |
| Total People Sold |
7 |
11 |
13 |
13 |
| Total Sell Transactions |
23 |
39 |
54 |
81 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Guthart Gary S |
President & CEO |
• • – |
2018-02-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(930) |
280,184 |
|
- |
|
| Guthart Gary S |
President & CEO |
• • – |
2018-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,875 |
281,114 |
|
- |
|
| Mohr Marshall |
SVP & CFO |
• – – |
2018-02-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(774) |
9,821 |
|
- |
|
| Mohr Marshall |
SVP & CFO |
• – – |
2018-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,560 |
10,595 |
|
- |
|
| Samath Jamie |
VP & Principal Accounting Offi |
• – – |
2018-02-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(387) |
1,715 |
|
- |
|
| Samath Jamie |
VP & Principal Accounting Offi |
• – – |
2018-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
780 |
2,102 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical OfficerEVP |
• – – |
2018-02-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(619) |
4,740 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical OfficerEVP |
• – – |
2018-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,248 |
5,359 |
|
- |
|
| Rosa David J. |
EVP & Chief Commercial Officer |
• – – |
2018-02-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(774) |
11,141 |
|
- |
|
| Rosa David J. |
EVP & Chief Commercial Officer |
• – – |
2018-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,560 |
11,915 |
|
- |
|
| Brogna Salvatore |
EVP & Chief Operating Officer |
• – – |
2018-02-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(774) |
5,597 |
|
- |
|
| Brogna Salvatore |
EVP & Chief Operating Officer |
• – – |
2018-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,560 |
6,371 |
|
- |
|
| Meltzer Mark J |
SVP General Counsel & CCO |
• – – |
2018-02-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(744) |
10,052 |
|
- |
|
| Meltzer Mark J |
SVP General Counsel & CCO |
• – – |
2018-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,500 |
10,796 |
|
- |
|
| Guthart Gary S |
President & CEO |
• • – |
2018-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,290) |
279,239 |
|
- |
|
| Guthart Gary S |
President & CEO |
• • – |
2018-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,600 |
280,529 |
|
- |
|
| Mohr Marshall |
SVP & CFO |
• – – |
2018-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,048) |
9,035 |
|
- |
|
| Mohr Marshall |
SVP & CFO |
• – – |
2018-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,112 |
10,083 |
|
- |
|
| Samath Jamie |
VP & Principal Accounting Offi |
• – – |
2018-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(349) |
1,322 |
|
- |
|
| Samath Jamie |
VP & Principal Accounting Offi |
• – – |
2018-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
731 |
1,671 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical OfficerEVP |
• – – |
2018-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(645) |
4,111 |
|
- |
|
| Myriam Curet |
EVP & Chief Medical OfficerEVP |
• – – |
2018-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,299 |
4,756 |
|
- |
|
| Rosa David J. |
EVP & Chief Commercial Officer |
• – – |
2018-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,128) |
10,355 |
|
- |
|
| Rosa David J. |
EVP & Chief Commercial Officer |
• – – |
2018-02-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,274 |
11,483 |
|
- |
|
| Brogna Salvatore |
EVP & Chief Operating Officer |
• – – |
2018-02-17 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,128) |
4,811 |
|
- |
|
1324 Records found
|
|
Page 32 of 53 |
|
|
5.92 (1.56%) 
